Explore more publications!

The Middle East Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.

Press releases published on November 4, 2025

Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2025 Financial Results
Supernus Announces Third Quarter 2025 Financial Results
Ultragenyx Announces Sale of a Portion of Future North American Royalties on Crysvita® (burosumab) for $400 Million to OMERS Life Sciences
Cytokinetics to Participate in November Investor Conferences
Lisata Therapeutics Highlights Positive Preclinical Data of Certepetide as Part of Antibody-Drug Conjugate Combinations as Reported by Licensing Partner Catalent
Day One Reports Third Quarter 2025 Financial Results and Corporate Progress
Smart Health Diagnostics Company Appoints Sarah Barry as Lead Controller to Oversee Finance Operations in Commercial Stage
Official Correction and Clarification from Daradia The Pain Clinic
Women’s Health Collective Canada and Partners Call for Bold Investment in Women’s Health to Close the Gap Once and for All
L’Association canadienne pour l’équité en santé des femmes et ses partenaires réclament un investissement audacieux dans la santé des femmes afin de combler définitivement les inégalités
Weltkongress der polnischen medizinischen Fachkreise „Save a Life“ 2025 – Eine weltweite Mission zur Förderung lebensrettender Fachkenntnisse
Édition 2025 du congrès mondial du collectif médical polonais « Save a Life » : une mission d’envergure mondiale répondant à l’objectif de faire progresser l’expertise en sauvetage de vies
Global Pain Management Devices Market Set to Expand Rapidly at a CAGR of ~8% by 2032 Amid Growing Preference for Minimally Invasive Solutions | DelveInsight
Fueling Discovery: Misophonia Research Fund Launches New Team Science Award, Expands 2026 Funding Opportunities, and Announces Latest Grantee Cohort
Chemed Corporation to Present at the UBS 2025 Global Healthcare Conference
Hengrui Pharma and Kailera Therapeutics Announce Additional Data from Phase 3 Obesity Trial in China of Dual GLP-1/GIP Receptor Agonist HRS9531 
Aardvark Therapeutics Presents Data Supporting its Metabolic Obesity Pipeline Programs at ObesityWeek 2025
Omada Health to Present Real-World Evidence at ObesityWeek 2025 Demonstrating Enhanced Outcomes for Current and Former GLP-1 Users
Humber River Health to Open James B. Neill Simulation Centre, Strengthening Ontario’s Healthcare Workforce and Advancing Innovative Patient Care
Baylor Genetics to Highlight Genetic Testing Use Cases and Advancements in Rare Disease at The National Society of Genetic Counselors 44th Annual Conference

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions